FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Realm US

12,851 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 10,870

 

Rows 0 - 200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
hl7.fhir.us.breastcancerR3shr-core-AllUnitsVSBC AllUnitsVS ValueSetdraft2018-08hl7ucum iso
us.cdc.phinvadsR41.3.6.1.4.1.19376.1.7.3.1.1.13.8.147Listeria (NCHS)active2014-01sct
us.cdc.phinvadsR41.3.6.1.4.1.19376.1.7.3.1.1.13.8.29Spinal Anesthesia - Procedure (NCHS)active2015-01sct
us.cdc.phinvadsR41.3.6.1.4.1.19376.1.7.3.1.1.23.8.6Death Certification (NCHS)active2015-01sct
us.cdc.phinvadsR42.16.840.1.113762.1.4.1010.9Substance Other Than Clinical Drug (NCHS)active2014-12sct
us.cdc.phinvadsR42.16.840.1.113883.1.11.10267Participation Function (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.1.11.10637Postal Address Use (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.1.11.12199Language Ability Proficiency (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.1.11.15913Entity Name Use (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.1.11.16866Act Priority (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.1.11.16926Basic Confidentiality Kind (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.1.11.19601x_ServiceEventPerformer (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.12.1Personal And Legal Relationship Role Type (HL7)active2014-12tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.18MoodCodeEvnInt (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.20Telecom Use - US Realm Header (HL7)active2014-12tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.22Procedure Act Status Code (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.23Planned moodCode - Act/Encounter/Procedure (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.24Planned moodCode - SubstanceAdministration/Supplyactive2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.26Entity Person Name Part Qualifier (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.33Role Class Codes (HL7)active2015-01tho
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.34Patient Educationactive2014-12sct
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.60Priority Level (NCHS)active2015-01sct
us.cdc.phinvadsR42.16.840.1.113883.3.520.4.29NAACCR SNOMEDCT Cancer Reportability Listactive2014-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3022PHIN Questions (Hepatitis)active2013-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3403Gender (Syndromic Surveillance)active2011-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3406Disease Acquired Jurisdiction (NETSS)active2011-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3407Case Class Status (NETSS)active2011-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3408Age Unit (NETSS)active2011-01ucum tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3411Body Region Tetanus (NETSS)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3412Injury Occurred Environment (NETSS)active2011-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3413Injury Type (NETSS)active2011-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3414Birth Attendees (NETSS)active2011-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3415Vaccines Administered (NETSS)active2011-01cvx tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3416Manufacturers Of Vaccines (NETSS)active2011-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3418Sexual Preference (NETSS)active2011-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3419Lab Test Result Lyme (NETSS)active2011-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3420Microorganism (NETSS)active2011-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3421Bacterial Infection Syndrome (NETSS)active2011-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3422Associated Conditions (NETSS)active2011-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3423Antibiotic Treatment (NETSS)active2011-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3424Hemodialysis Contact Type Hepatitis (NETSS)active2011-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3432Serogroup (NETSS)active2011-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3434Antimicrobial Agent NETSSactive2011-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3435Serotype (NETSS)active2011-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.5000Universal Identifier (HL7) (PHLIP)active2011-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.5002Order Control Codes (HL7) (PHLIP)active2011-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.5004Specimen Reject Reason (SCT) (PHLIP)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.5005Lab Test Order (PHLIP Sal)active2011-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.5006Value Type (HL7) (PHLIP)active2011-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.5007Specimen Related Observations (PHLIP Sal)active2011-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.5013Suspected Agent (PHLIP Sal)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.5014Observation Result Status (PHLIP)active2011-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.6067Universal ID Type (ELR)active2012-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.6069NAACCR ICD-10-CM Cancer Reportability Listactive2012-01icd
us.cdc.phinvadsR42.16.840.1.114222.4.11.6072Trachoma (NCHS)active2013-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7154Fetal Presentation at Birth- Unknown (NCHS)active2014-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7188Travel Reason (Hepatitis A)active2013-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7246Vital Signs (Syndromic Surveillance)active2014-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7247Symptoms (EVD Triage)active2014-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7248Countries Widespread Transmission (EVD)active2014-01iso
us.cdc.phinvadsR42.16.840.1.114222.4.11.7249Exposure Risk (EVD)active2014-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7250Observation Identifiers (EVD Triage)active2014-01sct loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7257Abdominal Pain (CDS - EHR)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7258Weakness (CDS - EHR)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7259Fever (CDS - EHR)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7260Headache (CDS - EHR)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7261Hemorrhage (CDS - EHR)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7262Muscle Pain (CDS - EHR)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7263Vomiting (CDS - EHR)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7264Diarrhea (CDS - EHR)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7275Nationally Notifiable Event Code (Hepatitis)active2015-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7331Vaccine Administered (MMR)active2015-01cvx tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7339Lab Test Name (Chikungunya virus)active2018-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7340Lab Test Name (Junin Hemorrhagic fever)active2015-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7341Lab Test Name (Lassa fever)active2015-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7342Lab Test Name (Marburgvirus)active2018-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7343Lab Result (Chikungunya virus)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7344Lab Result (Crimean-Congo hemorrhagic fever)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7345Lab Result (Guanarito hemorrhagic fever)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7346Lab Result (Junin hemorrhagic fever)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7347Lab Result (Lassa fever)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7348Lab Result (Lujo virus)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7349Lab Result (Machupo hemorrhagic fever)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7350Lab Result (Sabia virus hemorrhagic fever)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7395System Reject Codes (NCHS)active2015-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7398Nationally Notifiable Event Code (Syphilis)active2015-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7402Patient Residence (NCHS)active2014-12sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7403Injury or Poisoning (NCHS)active2014-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7404Major reason for visit (NCHS)active2014-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7405Co-morbid Conditions (NCHS)active2014-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7419Provider ED (NCHS)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7433Condition Control (NCHS)active2014-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7436Disposition (NCHS)active2014-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7439Episode of Care (NCHS)active2014-12sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7440Hospital Discharge Status (NCHS)active2014-12sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7478Serotype (Dengue)active2016-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7479Lab Result (Zika virus)active2016-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7515Data Elements (NND Hep Core)active2016-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7516Data Elements (NND Hep A Acute)active2016-01sct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7517Data Elements (NND Hep B Acute)active2016-01sct tho oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7518Data Elements (NND Hep B Perinatal)active2016-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7519Data Elements (NND Hep B Chronic)active2016-01sct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7520Data Elements (NND Hep C Acute)active2016-01sct tho oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7521Data Elements (NND Hep C Chronic)active2016-01sct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7522Data Elements (NND Mumps)active2016-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7523Data Elements (NND Pertussis)active2016-01sct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7524Data Elements (NND STD)active2016-01sct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7618Yes No Unknown Refused (NND)active2017-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7622Positive Negative Not Doneactive2017-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7628Yes No Unknown Maybe (FDD)active2017-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7629Yes No Don't Know Maybe (FDD)active2017-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7648Yes No Not Tested (NND)active2017-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.8065Occupation CDC Census 2018active2022-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.8066Industry CDC Census 2018active2022-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.8067Industry CDC NAICS 2017active2022-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.8068Occupation CDC SOC 2018active2022-01oid
signal.core.r4R42.16.840.1.113762.1.4.1021.32Gender Identityactive2022-03hl7vsac
us.nlm.vsacR41.2.91.13925.17760.1280649Sneezing and Itching Groupingactive2017-06vsac
us.nlm.vsacR41.2.91.13925.17760.15972546Conditions Indicating Appropriate Sinonasal Imagingactive2017-06vsac
us.nlm.vsacR41.2.91.13925.17760.16432390Cerumen Impactionactive2017-06vsac
us.nlm.vsacR41.2.91.13925.17760.16929355Allergic Rhinitis Groupingactive2017-06vsac
us.nlm.vsacR41.2.91.13925.17760.18316962Severe Asthmaactive2017-06vsac
us.nlm.vsacR41.2.91.13925.17760.19613338Immunoglobulin G Testing Groupingactive2022-03vsac
us.nlm.vsacR41.2.91.13925.17760.23618223Hearing Aids Groupingactive2017-06vsac
us.nlm.vsacR41.2.91.13925.17760.24927846Specific IgE testingactive2017-06cpt
us.nlm.vsacR41.2.91.13925.17760.26050446Ear Surgery Affecting the Tympanic Membraneactive2017-06cpt
us.nlm.vsacR41.2.91.13925.17760.26878039Specific IgE Testingactive2022-03vsac
us.nlm.vsacR41.2.91.13925.17760.29996863Immunoglobulin G testingactive2017-06cpt
us.nlm.vsacR41.2.91.13925.17760.4352590Benign Prostatic Hyperplasiaactive2017-08vsac
us.nlm.vsacR41.2.91.8867.26816.649902Office or Outpatient Encounteractive2017-07cpt
us.nlm.vsacR41.3.6.1.4.1.33895.1.3.0.45Comfort Measuresactive2021-02hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1pain medication action planactive2015-08hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.3.2All prescribable opioids used for pain control including Inactive Medicationsactive2015-08hl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.1malignant neoplasms and cancer painactive2015-08hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.2malignant neoplasms and cancer painactive2015-08hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.7malignant neoplasms and cancer painactive2015-08hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.9malignancy or cancer related painactive2015-08hl7vsac
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150Cerumen on Otoscopyactive2017-02hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151Cerumen on Otoscopyactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152Cerumen on Otoscopyactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172Hearing Lossactive2017-02hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173Hearing Lossactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174Hearing Lossactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175Tinnitusactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176Tinnitusactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177Tinnitusactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178Ear Congestionactive2017-02hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179Ear Pruritusactive2017-02hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180Otalgiaactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181Otalgiaactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182Otalgiaactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96Initial Encounter with Otolaryngologist or undefined clinicianactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204Hearing Aidsactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205Hearing Aidsactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206Hearing Aidsactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81Cerumen Impactionactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82Cerumen Impactionactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190Radiotherapyactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191Head and Neck Anatomic Locationsactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192Conditions Associated with Head and Neck Radiotherapyactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194Ear Canal Stenosisactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195Ear Canal Stenosisactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196Ear Canal Stenosisactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197Exostosesactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198Exostosesactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199Exostosesactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200Non intact Tympanic Membraneactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201Non Intact Tympanic Membraneactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202Non Intact Tympanic Membraneactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246Hearing Aidsactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250DO NOT USEactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251Cerumenolyticsactive2017-03hl7rx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252Irrigationactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253Irrigationactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288Otoscopy performed on examactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291Otolaryngologist as a Clinician or Serviceactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123Cerumen Impactionactive2017-02hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275Dermatologic Diseases of the Earactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20Keratoses Obturansactive2017-02hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221Tympanoplastyactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222Tympanoplastyactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223Myringoplastyactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224Myringoplastyactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225Mastoidectomyactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229Mastoidectomyactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227Ear Surgery, Otheractive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228Ear Surgery, Otheractive2018-01hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334Sleep Apneaactive2018-05hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336Sleep Apneaactive2018-05hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237Allergic Rhinitisactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238Allergic Rhinitisactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239Allergic Rhinitisactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263Uncontrolled or severe asthmaactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264Uncontrolled or severe asthmaactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265Uncontrolled or severe asthmaactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300Rhinosinusitisactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301Rhinosinusitisactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302Rhinosinusitisactive2017-03hl7sct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303Nasal Polyposisactive2017-03hl7icd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304Nasal Polyposisactive2017-03hl7icd